Park Ha Biological Technology Co Ltd Faces Turbulence in Skincare Sector Amid Financial Struggles
Park Ha Biological Technology Co Ltd’s stock has plummeted from a 52-week high of $41.49 to a mere $0.82, raising concerns about the company’s strategic direction and market viability in the skincare industry.
- Park Ha Biological Technology Co Ltd
- Consumer Discretionary
- Consumer Discretionary Distribution & Retail
- AI generated
3 minutes to read